Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 2.58 CAD 3.2% Market Closed
Market Cap: 118.6m CAD
Have any thoughts about
Theratechnologies Inc?
Write Note

Wall Street
Price Targets

TH Price Targets Summary
Theratechnologies Inc

Wall Street analysts forecast TH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TH is 6.02 CAD with a low forecast of 3.84 CAD and a high forecast of 8.4 CAD.

Lowest
Price Target
3.84 CAD
49% Upside
Average
Price Target
6.02 CAD
133% Upside
Highest
Price Target
8.4 CAD
226% Upside
Theratechnologies Inc Competitors:
Price Targets
ELUT
Elutia Inc
110% Upside
UTHR
United Therapeutics Corp
10% Upside
XNCR
Xencor Inc
37% Upside
BEAM
Beam Therapeutics Inc
75% Upside
INSM
Insmed Inc
29% Upside
BIOPOR
Bioporto A/S
105% Upside
301080
Acrobiosystems Co Ltd
9% Upside
688520
Sinocelltech Group Ltd
77% Upside

Revenue
Forecast

Revenue Estimate
Theratechnologies Inc

For the last 8 years the compound annual growth rate for Theratechnologies Inc's revenue is 17%. The projected CAGR for the next 4 years is 8%.

17%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Theratechnologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Theratechnologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TH's stock price target?
Price Target
6.02 CAD

According to Wall Street analysts, the average 1-year price target for TH is 6.02 CAD with a low forecast of 3.84 CAD and a high forecast of 8.4 CAD.

What is Theratechnologies Inc's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Theratechnologies Inc's revenue is 17%. The projected CAGR for the next 4 years is 8%.

Back to Top